|

A Nurse-Led Weight Monitoring Intervention For Heart Failure Quality of LIfe and Self-Care

RECRUITINGN/ASponsored by Lee Anne Siegmund
Actively Recruiting
PhaseN/A
SponsorLee Anne Siegmund
Started2024-11-01
Est. completion2026-10-31
Eligibility
Age55 Years+
Healthy vol.Accepted
Locations1 site

Summary

Ongoing self-care for heart failure is essential to avoid complications and hospitalization. Supportive strategies are needed; however, patients with heart failure may find many interventions complicated and overwhelming. The purpose of this pilot study is to implement a simple weight tracking tool (Wake and Weigh) to affect self-care and quality of life in a population of older adults with heart failure. This will be a randomized controlled pilot trial to test the methods to be used in a larger randomized controlled trial. The Self-care in Heart Failure Index and Kansas City Cardiomyopathy Questionnaire surveys will be given at admission and four weeks after discharge. The Wake and Weigh tool is designed to help patients track weight in the hospital and following discharge. Feasibility endpoints will be summarized descriptively.

Eligibility

Age: 55 Years+Healthy volunteers accepted
Inclusion Criteria:

1. Adults (55 years or older)
2. New or existing diagnosis of HF (regardless of type or length of time since diagnosis).
3. Being treated for HF signs and/or symptoms during the current hospitalization (any of the following: IV diuretic, fluid restriction, low sodium diet).
4. Must be able to read and communicate in English.
5. Must be able to stand and weigh independently.
6. Must have a scale at home, or ability to obtain one for the study.

Exclusion Criteria:

1. Documented diagnosis of cognitive impairment.
2. A Charlson Comorbidity Index (CCI) of \>4. This was chosen to exclude patients more likely to have hospital stays longer than a week. A CCI of \>3 was based on research showing a relationship to mortality (Imam et al., 2020), a CCI of ≥ 6 with a 2.8-times higher mortality (Yilmaz \& Omurlu, 2019), and likelihood of longer hospital length of stay for patients with HF if CCI \>2 (Foraker et al., 2014).

Conditions2

Heart DiseaseHeart Failure

Locations1 site

Cleveland Clinic Avon Hospital
Avon, Ohio, 44011
Michelle Thomas, MSN, ACCNS-AG216-440-8706thomasm3@ccf.org

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.